Real-World Comparative Observational Study in Non-Valvular Atrial Fibrillation Patients Using Oral Anticoagulants

NCT02754154 · clinicaltrials.gov ↗

COMPLETED

Status

321182

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Warfarin
DRUG: Apixaban
DRUG: Dabigatran
DRUG: Rivaroxaban

Sponsor

Bristol-Myers Squibb